Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.

Lancet (London, England) ·Vol. 346 ·No. 8974 ·1995-08-26 ·Pages 578

Costagliola D, Mary-Krause M

Abstract

暂无摘要

MeSH Terms

AIDS-Related Opportunistic Infections/prevention & control Acyclovir/therapeutic use Antiviral Agents/therapeutic use Bias Female Follow-Up Studies Foscarnet/therapeutic use Ganciclovir/therapeutic use HIV Seropositivity Humans Information Systems Male Proportional Hazards Models Risk Factors Sarcoma, Kaposi/prevention & control

Chemicals

Antiviral Agents Foscarnet Ganciclovir Acyclovir

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Costagliola D

Mary-Krause M

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

10.1016/s0140-6736(95)91417-x

Published

1995-08-26

Pages

578

Language

English

Region

England

NLM ID

2985213R

Subset

External Links

PubMed source DOI: 10.1016/s0140-6736(95)91417-x View journal details

Analysis Services

Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.

Contact

WeChat Official Account